9th Circ. Affirms Toss Of Suit Over Peregrine Drug Claims
The Ninth Circuit on Wednesday declined to bring back a dismissed securities class action against Peregrine Pharmaceuticals Inc. alleging the company intentionally misled investors about clinical test results for a lung...To view the full article, register now.
Already a subscriber? Click here to view full article